Duration of Infectious Virus Shedding by SARS-CoV-2 Omicron Variant–Infected Vaccinees

To determine virus shedding duration, we examined clinical samples collected from the upper respiratory tracts of persons infected with severe acute respiratory syndrome coronavirus 2 Omicron variant in Japan during November 29-December 18, 2021. Vaccinees with mild or asymptomatic infection shed in...

Full description

Saved in:
Bibliographic Details
Published inEmerging infectious diseases Vol. 28; no. 5; pp. 998 - 1001
Main Authors Takahashi, Kenichiro, Ishikane, Masahiro, Ujiie, Mugen, Iwamoto, Noriko, Okumura, Nobumasa, Sato, Testsuro, Nagashima, Maki, Moriya, Ataru, Suzuki, Michiyo, Hojo, Masayuki, Kanno, Takayuki, Saito, Shinji, Miyamoto, Sho, Ainai, Akira, Tobiume, Minoru, Arashiro, Takeshi, Fujimoto, Tsuguto, Saito, Tomoya, Yamato, Masaya, Suzuki, Tadaki, Ohmagari, Norio
Format Journal Article
LanguageEnglish
Published United States U.S. National Center for Infectious Diseases 01.05.2022
Centers for Disease Control and Prevention
Subjects
Online AccessGet full text

Cover

Loading…
Abstract To determine virus shedding duration, we examined clinical samples collected from the upper respiratory tracts of persons infected with severe acute respiratory syndrome coronavirus 2 Omicron variant in Japan during November 29-December 18, 2021. Vaccinees with mild or asymptomatic infection shed infectious virus 6-9 days after onset or diagnosis, even after symptom resolution.
AbstractList To determine virus shedding duration, we examined clinical samples collected from the upper respiratory tracts of persons infected with severe acute respiratory syndrome coronavirus 2 Omicron variant in Japan during November 29-December 18, 2021. Vaccinees with mild or asymptomatic infection shed infectious virus 6-9 days after onset or diagnosis, even after symptom resolution.To determine virus shedding duration, we examined clinical samples collected from the upper respiratory tracts of persons infected with severe acute respiratory syndrome coronavirus 2 Omicron variant in Japan during November 29-December 18, 2021. Vaccinees with mild or asymptomatic infection shed infectious virus 6-9 days after onset or diagnosis, even after symptom resolution.
To determine virus shedding duration, we examined clinical samples collected from the upper respiratory tracts of persons infected with severe acute respiratory syndrome coronavirus 2 Omicron variant in Japan during November 29-December 18, 2021. Vaccinees with mild or asymptomatic infection shed infectious virus 6-9 days after onset or diagnosis, even after symptom resolution.
Audience Professional
Academic
Author Okumura, Nobumasa
Saito, Tomoya
Suzuki, Tadaki
Hojo, Masayuki
Kanno, Takayuki
Ohmagari, Norio
Nagashima, Maki
Tobiume, Minoru
Fujimoto, Tsuguto
Saito, Shinji
Ujiie, Mugen
Moriya, Ataru
Miyamoto, Sho
Ishikane, Masahiro
Iwamoto, Noriko
Arashiro, Takeshi
Yamato, Masaya
Takahashi, Kenichiro
Suzuki, Michiyo
Sato, Testsuro
Ainai, Akira
Author_xml – sequence: 1
  givenname: Kenichiro
  surname: Takahashi
  fullname: Takahashi, Kenichiro
– sequence: 2
  givenname: Masahiro
  surname: Ishikane
  fullname: Ishikane, Masahiro
– sequence: 3
  givenname: Mugen
  surname: Ujiie
  fullname: Ujiie, Mugen
– sequence: 4
  givenname: Noriko
  surname: Iwamoto
  fullname: Iwamoto, Noriko
– sequence: 5
  givenname: Nobumasa
  surname: Okumura
  fullname: Okumura, Nobumasa
– sequence: 6
  givenname: Testsuro
  surname: Sato
  fullname: Sato, Testsuro
– sequence: 7
  givenname: Maki
  surname: Nagashima
  fullname: Nagashima, Maki
– sequence: 8
  givenname: Ataru
  surname: Moriya
  fullname: Moriya, Ataru
– sequence: 9
  givenname: Michiyo
  surname: Suzuki
  fullname: Suzuki, Michiyo
– sequence: 10
  givenname: Masayuki
  surname: Hojo
  fullname: Hojo, Masayuki
– sequence: 11
  givenname: Takayuki
  surname: Kanno
  fullname: Kanno, Takayuki
– sequence: 12
  givenname: Shinji
  surname: Saito
  fullname: Saito, Shinji
– sequence: 13
  givenname: Sho
  surname: Miyamoto
  fullname: Miyamoto, Sho
– sequence: 14
  givenname: Akira
  surname: Ainai
  fullname: Ainai, Akira
– sequence: 15
  givenname: Minoru
  surname: Tobiume
  fullname: Tobiume, Minoru
– sequence: 16
  givenname: Takeshi
  surname: Arashiro
  fullname: Arashiro, Takeshi
– sequence: 17
  givenname: Tsuguto
  surname: Fujimoto
  fullname: Fujimoto, Tsuguto
– sequence: 18
  givenname: Tomoya
  surname: Saito
  fullname: Saito, Tomoya
– sequence: 19
  givenname: Masaya
  surname: Yamato
  fullname: Yamato, Masaya
– sequence: 20
  givenname: Tadaki
  surname: Suzuki
  fullname: Suzuki, Tadaki
– sequence: 21
  givenname: Norio
  surname: Ohmagari
  fullname: Ohmagari, Norio
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35290176$$D View this record in MEDLINE/PubMed
BookMark eNqNk9uK2zAQhk3Z0j20t70shkJpL5xKsmxFN4WQngILgU0beidkaewoOPKuZZfuXd-hb9gn6WSTPbikUAyWNP7-35Jm5jQ68o2HKHpOyShlhL4FZ9mYZCOGCykeRSeUjEmSk0we3c05OY5OQ1gTQrfUk-g4zZgkVOQn0bf3fas71_i4KeOZL8Hgog_x0rX4XqzAWueruLiOF5OLRTJtlgmL5xtnWpQsdeu0737__LVTgsWQMc4DhKfR41LXAZ7tx7Po68cPX6afk_P5p9l0cp4YkfEuKblFpUnzXMsiZcBSaQvLUgGa2TLfDhmxlEhaZJxLQymFghQkLce5TSVNz6LZztc2eq0uW7fR7bVqtFM3gaatlG47Z2pQYyFzycvc2MJwIgpZSEZEllIAkWXaote7nddlX2zAGvBdq-uB6fCLdytVNd-VJBx3l6LB671B21z1EDq1ccFAXWsPeKuK5ZwQLsWYIfryL3Td9K3Hq0JKcCqYIPyeqjQewPmywf-aramaCELHKcszgVRygKrAA24S66V0GB7wowM8PhYwswcFbwYCZDr40VW6D0HNFhf_z86XQ_bVA3YFuu5Woan7bUGGIfjiYWbuUnJbyAjwHYCFGUILpTKuuylsPJqrFSVq2y9q3y9q1y_3N3Enu3X-h-APAtMRxQ
CitedBy_id crossref_primary_10_1016_j_ijid_2023_02_020
crossref_primary_10_1016_j_scitotenv_2024_175724
crossref_primary_10_1016_j_ijid_2023_03_029
crossref_primary_10_3389_fmicb_2023_1229234
crossref_primary_10_1016_S2666_5247_23_00146_5
crossref_primary_10_1016_j_isci_2023_108336
crossref_primary_10_1038_s41579_022_00822_w
crossref_primary_10_3389_fpubh_2022_1015811
crossref_primary_10_3346_jkms_2023_38_e59
crossref_primary_10_1128_spectrum_05346_22
crossref_primary_10_1002_jmv_29708
crossref_primary_10_1136_rmdopen_2022_002587
crossref_primary_10_4178_epih_e2023008
crossref_primary_10_1371_journal_pone_0285704
crossref_primary_10_1016_j_jinf_2022_07_027
crossref_primary_10_1016_j_jiph_2022_06_020
crossref_primary_10_1016_j_jiac_2023_09_023
crossref_primary_10_1016_j_jconrel_2024_05_041
crossref_primary_10_3390_covid3100108
crossref_primary_10_1111_irv_13044
crossref_primary_10_1093_cid_ciad535
crossref_primary_10_1016_j_jiac_2025_102631
crossref_primary_10_1038_s41467_023_36984_1
crossref_primary_10_1016_j_ijid_2023_02_011
crossref_primary_10_1186_s12879_023_08582_5
crossref_primary_10_1186_s12879_024_09633_1
crossref_primary_10_3390_covid2080074
crossref_primary_10_1097_IPC_0000000000001419
crossref_primary_10_1371_journal_pcbi_1012345
crossref_primary_10_1073_pnas_2314808120
crossref_primary_10_1016_j_virs_2024_10_001
crossref_primary_10_1097_JOM_0000000000002669
crossref_primary_10_1016_j_focus_2024_100207
crossref_primary_10_1093_cid_ciad685
crossref_primary_10_1016_j_cmi_2022_07_009
crossref_primary_10_1128_spectrum_01922_22
crossref_primary_10_3201_eid2810_220494
crossref_primary_10_1016_j_isci_2023_105969
crossref_primary_10_3390_v16040649
crossref_primary_10_3390_v15010013
crossref_primary_10_1186_s12879_023_08821_9
crossref_primary_10_3389_fpubh_2024_1377135
crossref_primary_10_1016_j_intimp_2022_109534
crossref_primary_10_1016_j_jiac_2024_07_004
crossref_primary_10_3389_fmed_2022_988559
crossref_primary_10_1186_s12879_022_07935_w
crossref_primary_10_2807_1560_7917_ES_2023_28_4_2300007
crossref_primary_10_1038_s41579_023_01001_1
crossref_primary_10_3390_v14081714
crossref_primary_10_1093_infdis_jiad314
crossref_primary_10_2222_jsv_74_29
crossref_primary_10_1136_bmjopen_2023_073084
crossref_primary_10_1002_jmv_29228
crossref_primary_10_1002_biot_202400447
crossref_primary_10_2169_naika_112_427
crossref_primary_10_3390_v16071131
Cites_doi 10.1093/cid/ciab1072
10.1001/jamainternmed.2020.2020
10.35772/ghm.2021.01124
10.2807/1560-7917.ES.2021.26.37.2100824
10.7883/yoken.JJID.2020.061
10.1056/NEJMc2102507
10.1093/infdis/jiab107
10.1172/jci.insight.155483
10.1136/bmjresp-2020-000830
10.1038/s41591-020-0869-5
ContentType Journal Article
Copyright COPYRIGHT 2022 U.S. National Center for Infectious Diseases
Published 2022. This article is a U.S. Government work and is in the public domain in the USA.
2022
Copyright_xml – notice: COPYRIGHT 2022 U.S. National Center for Infectious Diseases
– notice: Published 2022. This article is a U.S. Government work and is in the public domain in the USA.
– notice: 2022
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
IOV
ISR
3V.
7RV
7X7
7XB
8C1
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
AZQEC
BENPR
CCPQU
FYUFA
GHDGH
K9-
K9.
KB0
M0R
M0S
NAPCQ
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
7X8
5PM
DOA
DOI 10.3201/eid2805.220197
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Gale In Context: Opposing Viewpoints
Gale In Context: Science
ProQuest Central (Corporate)
Nursing & Allied Health Database
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Public Health Database
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One
Proquest Health Research Premium Collection
Health Research Premium Collection (Alumni)
Consumer Health Database (Alumni Edition)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
Consumer Health Database
ProQuest Health & Medical Collection
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Family Health (Alumni Edition)
ProQuest Central
ProQuest One Sustainability
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Health & Medical Research Collection
ProQuest Central (New)
ProQuest Public Health
ProQuest Family Health
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
ProQuest One Academic Middle East (New)


Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Public Health
DocumentTitleAlternate Virus Shedding by Omicron-Infected Vaccinees
EISSN 1080-6059
EndPage 1001
ExternalDocumentID oai_doaj_org_article_879694f6cdbc407b9b9207531ee755ad
PMC9045443
A701832657
35290176
10_3201_eid2805_220197
Genre Journal Article
GeographicLocations Japan
GeographicLocations_xml – name: Japan
GroupedDBID ---
-~X
.GJ
186
29G
2WC
36B
53G
5GY
5VS
6PF
7RV
7X7
85S
8C1
8FI
8FJ
9K5
A8Z
AAWTL
AAYOK
AAYXX
ABDBF
ABUWG
ACGFO
ACUHS
ADBBV
ADRAZ
AEGXH
AENEX
AETEA
AEUYN
AFKRA
AIAGR
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
B0M
BAWUL
BCNDV
BENPR
C1A
CCPQU
CITATION
DIK
DO4
E3Z
EAD
EAP
EAS
EBC
EBD
EBS
EDH
EJD
EMB
EMH
EMI
EMK
EMOBN
EPL
EPT
ESX
F5P
FRP
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
IBB
IEA
IEP
IHR
IHW
IMI
INH
INR
IOF
IOV
IPO
ISR
ITC
K9-
KQ8
M0R
M48
NAPCQ
NEJ
O5R
O5S
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PV9
Q.E
QF4
QM9
QN7
QO4
Q~Q
RGD
RGQ
RNS
RPM
RXW
RZL
SV3
TAE
TR2
TUS
TWZ
UKHRP
UQL
W2D
WH7
WOQ
WOW
XJT
XSB
YRT
YV5
YXF
ZBA
ZGI
~8M
CGR
CUY
CVF
ECM
EIF
NPM
PJZUB
PPXIY
PMFND
3V.
7XB
8FK
K9.
PKEHL
PQEST
PQQKQ
PQUKI
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c754t-f4dfecc366a9b32e239dbd237ea2df67ea250d1091b5449c111eb0b03f86d3913
IEDL.DBID M48
ISSN 1080-6040
1080-6059
IngestDate Wed Aug 27 01:32:08 EDT 2025
Thu Aug 21 18:01:56 EDT 2025
Mon Jul 21 09:20:59 EDT 2025
Sat Jul 26 03:31:05 EDT 2025
Tue Jun 17 21:37:26 EDT 2025
Thu Jun 12 20:44:52 EDT 2025
Tue Jun 10 20:43:13 EDT 2025
Fri Jun 27 03:37:28 EDT 2025
Fri Jun 27 04:02:09 EDT 2025
Thu May 22 21:24:21 EDT 2025
Mon Jul 21 06:00:18 EDT 2025
Thu Apr 24 22:56:49 EDT 2025
Tue Jul 01 03:30:03 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords viruses
vaccines
Japan
zoonoses
respiratory infections
COVID-19
SARS-CoV-2
severe acute respiratory syndrome coronavirus 2
viral shedding
variant of concern
2019 novel coronavirus disease
coronavirus disease
Omicron
Language English
License Emerging Infectious Diseases is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c754t-f4dfecc366a9b32e239dbd237ea2df67ea250d1091b5449c111eb0b03f86d3913
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://doaj.org/article/879694f6cdbc407b9b9207531ee755ad
PMID 35290176
PQID 2674172704
PQPubID 105375
PageCount 4
ParticipantIDs doaj_primary_oai_doaj_org_article_879694f6cdbc407b9b9207531ee755ad
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9045443
proquest_miscellaneous_2640049782
proquest_journals_2674172704
gale_infotracmisc_A701832657
gale_infotracgeneralonefile_A701832657
gale_infotracacademiconefile_A701832657
gale_incontextgauss_ISR_A701832657
gale_incontextgauss_IOV_A701832657
gale_healthsolutions_A701832657
pubmed_primary_35290176
crossref_citationtrail_10_3201_eid2805_220197
crossref_primary_10_3201_eid2805_220197
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2022-05-00
20220501
2022-05-01
PublicationDateYYYYMMDD 2022-05-01
PublicationDate_xml – month: 05
  year: 2022
  text: 2022-05-00
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Atlanta
PublicationTitle Emerging infectious diseases
PublicationTitleAlternate Emerg Infect Dis
PublicationYear 2022
Publisher U.S. National Center for Infectious Diseases
Centers for Disease Control and Prevention
Publisher_xml – name: U.S. National Center for Infectious Diseases
– name: Centers for Disease Control and Prevention
References He (key-10.3201/eid2805.220197-202204181301-R8) 2020; 26
Kissler (key-10.3201/eid2805.220197-202204181301-R10) 2021; 385
Shirato (key-10.3201/eid2805.220197-202204181301-R6) 2020; 73
Owusu (key-10.3201/eid2805.220197-202204181301-R11) 2021; 224
Siedner (key-10.3201/eid2805.220197-202204181301-R13) 2022; 7
Maruki (key-10.3201/eid2805.220197-202204181301-R2) 2022
key-10.3201/eid2805.220197-202204181301-R14
key-10.3201/eid2805.220197-202204181301-R5
key-10.3201/eid2805.220197-202204181301-R4
Blanquart (key-10.3201/eid2805.220197-202204181301-R12) 2021; 26
key-10.3201/eid2805.220197-202204181301-R3
key-10.3201/eid2805.220197-202204181301-R1
Yamada (key-10.3201/eid2805.220197-202204181301-R7) 2021; 8
Cheng (key-10.3201/eid2805.220197-202204181301-R9) 2020; 180
References_xml – volume: •••
  start-page: ciab1072
  year: 2022
  ident: key-10.3201/eid2805.220197-202204181301-R2
  article-title: Two cases of breakthrough SARS-CoV-2 infections caused by the Omicron variant (B.1.1.529 lineage) in international travelers to Japan.
  publication-title: Clin Infect Dis
  doi: 10.1093/cid/ciab1072
– ident: key-10.3201/eid2805.220197-202204181301-R14
– ident: key-10.3201/eid2805.220197-202204181301-R3
– ident: key-10.3201/eid2805.220197-202204181301-R1
– volume: 180
  start-page: 1156
  year: 2020
  ident: key-10.3201/eid2805.220197-202204181301-R9
  article-title: Contact tracing assessment of COVID-19 transmission dynamics in Taiwan and risk at different exposure periods before and after symptom onset.
  publication-title: JAMA Intern Med
  doi: 10.1001/jamainternmed.2020.2020
– ident: key-10.3201/eid2805.220197-202204181301-R5
  doi: 10.35772/ghm.2021.01124
– ident: key-10.3201/eid2805.220197-202204181301-R4
– volume: 26
  start-page: 34533119
  year: 2021
  ident: key-10.3201/eid2805.220197-202204181301-R12
  article-title: Characterisation of vaccine breakthrough infections of SARS-CoV-2 Delta and Alpha variants and within-host viral load dynamics in the community, France, June to July 2021.
  publication-title: Euro Surveill
  doi: 10.2807/1560-7917.ES.2021.26.37.2100824
– volume: 73
  start-page: 304
  year: 2020
  ident: key-10.3201/eid2805.220197-202204181301-R6
  article-title: Development of genetic diagnostic methods for detection for novel coronavirus 2019(nCoV-2019) in Japan.
  publication-title: Jpn J Infect Dis
  doi: 10.7883/yoken.JJID.2020.061
– volume: 385
  start-page: 2489
  year: 2021
  ident: key-10.3201/eid2805.220197-202204181301-R10
  article-title: Viral dynamics of SARS-CoV-2 variants in vaccinated and unvaccinated persons.
  publication-title: N Engl J Med
  doi: 10.1056/NEJMc2102507
– volume: 224
  start-page: 1362
  year: 2021
  ident: key-10.3201/eid2805.220197-202204181301-R11
  article-title: Persistent SARS-CoV-2 RNA shedding without evidence of infectiousness: a cohort study of individuals with COVID-19.
  publication-title: J Infect Dis
  doi: 10.1093/infdis/jiab107
– volume: 7
  start-page: e155483
  year: 2022
  ident: key-10.3201/eid2805.220197-202204181301-R13
  article-title: Duration of viral shedding and culture positivity with postvaccination SARS-CoV-2 delta variant infections.
  publication-title: JCI Insight
  doi: 10.1172/jci.insight.155483
– volume: 8
  start-page: e000830
  year: 2021
  ident: key-10.3201/eid2805.220197-202204181301-R7
  article-title: Assessment of SARS-CoV-2 infectivity of upper respiratory specimens from COVID-19 patients by virus isolation using VeroE6/TMPRSS2 cells.
  publication-title: BMJ Open Respir Res
  doi: 10.1136/bmjresp-2020-000830
– volume: 26
  start-page: 672
  year: 2020
  ident: key-10.3201/eid2805.220197-202204181301-R8
  article-title: Temporal dynamics in viral shedding and transmissibility of COVID-19.
  publication-title: Nat Med
  doi: 10.1038/s41591-020-0869-5
SSID ssj0012019
Score 2.591018
Snippet To determine virus shedding duration, we examined clinical samples collected from the upper respiratory tracts of persons infected with severe acute...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 998
SubjectTerms 2019 novel coronavirus disease
Airports
Asymptomatic
Asymptomatic Infections
Communicable Diseases
coronavirus disease
Coronaviruses
COVID-19
COVID-19 vaccines
Dispatch
Duration of Infectious Virus Shedding by SARS-CoV-2 Omicron Variant–Infected Vaccinees
Genomes
Humans
Infections
Infectious disease incubation period
Infectious diseases
Medical research
Patients
Respiratory tract
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Virus research
Virus Shedding
Viruses
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9NAEF6hnpAQ4o1LgQUhejK19-XsMRSqFgkqNTTKbeX17raRwEFNcuDGf-Af8kuY8W6sWIDgwCWRdj8r0cx4HvbMt4S8CEh-W3ieN9KrXARW57XlKg9qxOsSh7o6dv33H9TxuXg3k7Oto76wJyzSA0fBHYwqrbQIqnG2geLDaqsZhDleel9JWTv0vhDzNsVUen8AYU3H1noojsBOI10jh-UDP3dsVMhXDDHVIBx1rP2_-uat4DRsnNyKREe3yM2UQtJx_Ou3yTXf3iE34vM3GseK7pLZm3XULV0EepI6rtZLOp1fwefk0jsMWtR-pZPx2SQ_XExzRk8_Y3teS6dQQIPEf3z7Hq_0DpYafAXvl_fI-dHbj4fHeTpFIW8qKVZ5EA6QDVeq1pYzz7h21jFe-Zq5oPBLFg75Qa0UQjfg_LwtbMHDSDmuS36f7LSL1j8kVGpRW8gwZa28KIPUtgxOMcgRrAog64zkG2GaJlGM40kXnwyUGih8k4RvovAzst_jv0RyjT8iX6NuehSSYncLYCommYr5m6lk5Clq1sQJ0_7WNuOqQMemJPzM8w6BxBgtdt5c1Ovl0pycTv8BNDkbgPYTKCxABE2dph1AkEi4NUC-HCAvIt3474B7AyD4gWa4vTFYk_zQ0jAFGSOkqIXIyLN-G6_E3rrWg-EBBv24hlQxIw-iffdyhvQcEsZKZaQaWP5AEcOddn7ZsZRrJHcUfPd_aO4Ruc5w7KRrNN0jO6urtX8MyeDKPunu-5_HcVfe
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1bb9MwFLZgvCAhxJ2MAQEh9hSW2LFTP6EymDYkmLSyqm9RfOsqQbI17QNv_Af-Ib-Ec2I3LOIiXlrJ_qJW59jn4pzzmZAXDslvU8sSza1IckerpFJMJE6MWJVhU1fHrv_hozg8zd_P-CwcuLWhrHJjEztDbRqNZ-R7VIDvA2eb5q_PLxK8NQrfroYrNK6Sa0hdhiVdxaxPuDJwbtIX2EOKBKvVkzYyGN6zC0NHKX9FEVMMnFLH3f-7hb7kooblk5f80cEtcjMEkvHYa_42uWLrO-SGP4WLfXPRXTJ7u_YajhsXH4W6q3UbTxdL-JycWYOuK1Zf48n4ZJLsN9OExsdfsEivjqeQRoPcf3z77p-0BoY0voi37T1yevDu0_5hEu5SSHTB81XicgNIzYSopGLUUiaNMpQVtqLGCfziqUGWUMXzXGowgValKmVuJAyTGbtPtuqmtg9JzGVeKYgzeSVsnjkuVeaMoBApKOFA1hFJNsIsdSAax_suPpeQcKDwyyD80gs_Irs9_txTbPwV-QZ106OQGrsbaJbzMuy0clRIIXMntFEaslUllaQQF7HM2oLzykTkKWq29H2m_QYvx0WK5k1w-JnnHQLpMWqsv5lX67Ytj46n_wGanAxAuwHkGhCBrkLPAwgSabcGyJcD5NyTjv8JuDMAgjXQw-nNgi2DNWrLX3snIs_6aXwSK-xqCwsPMGjNJQSMEXng13cvZwjSIWwsRESKwcofKGI4Uy_OOq5yiRSPOdv-9996RK5TbCvpCkl3yNZqubaPIdhbqSfdjv4Jq6VPfQ
  priority: 102
  providerName: ProQuest
Title Duration of Infectious Virus Shedding by SARS-CoV-2 Omicron Variant–Infected Vaccinees
URI https://www.ncbi.nlm.nih.gov/pubmed/35290176
https://www.proquest.com/docview/2674172704
https://www.proquest.com/docview/2640049782
https://pubmed.ncbi.nlm.nih.gov/PMC9045443
https://doaj.org/article/879694f6cdbc407b9b9207531ee755ad
Volume 28
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELfY9oKEEN8URgkIsadsib9SPyDUdqs2pG2opVXfoji2u0ojhX5I7L_nLk67RRRpL4ka_6xK5zvfXXL3MyGfHJLfRpaFubAy5I5mYaaZDJ1ssSzGpq6SXf_8Qp4O-bexGN_WP1UCXGxN7fA8qeH8-vDP75uvYPBfMOME_3Vkp4a2InFI4YdKdsgeeKUEjfSc335RwDFfbA_pEmiuJ3DcMr_moEoe_3936zvuql5Kecc39Z6Qx1VQGbS9FjwlD2zxjDzyb-QC32j0nIyOV361g5kLzqoarNUiGE3ncB1cWYNuLNA3waDdH4Td2SikweVPLNgrghGk1LAGoZ9nDTzI8ZO8Xbwgw97Jj-5pWJ2qEOaJ4MvQcQPInEmZKc2opUwZbShLbEaNk3gTkUG-UC04VzlshlZHOmKuJQ1TMXtJdotZYV-TQCieaYg4RSYtj51QOnZGUogZtHQg6QYJ16JM84pyHE--uE4h9UDRp5XoUy_6BjnY4H95so3_Iju4MhsUkmSXD2bzSVrZXNpKlFTcydzoHPJWrbSiECGx2NpEiMw0yHtc19R3nG5MPW0nEW50UsDffCwRSJRRYCXOJFstFunZ5egeoEG_BjqoQG4GIsizqvsBBIkEXDXk5xpy4unHtwH3a0DYF_L68Fpd07VZpVRCBAkha8Qb5MNmGGdirV1hQe0Ag_u6gtCxQV557d7IGcJ1CCAT2SBJTe9rC1EfKaZXJWu5QrJHzt7cR1pvyUOKbSZlYek-2V3OV_YdBH9L3SQ7yTiBa6sbN8leu3Pc6cG9c3Lxvd8sX6g0S7v_C6F5WCo
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKOYCEEG8ChQYE9JQ2sRNnfUBoaam69CV129XeTBzb25UgKfsQ6o3_wP_gR_FLmImzoREPcellV7K_7Ebj8TySmc-EvLBIfhsaFuSJ4UFsaRZkivHA8g7LImzqqtj19w_4zkn8fpgMl8j3RS8MllUubGJlqHWZ4zPyDcrB94GzDeM3Z58DPDUK364ujtBwarFrzr9AyjZ93duC9X1J6fa7482doD5VIMjTJJ4FNtYW7ptxngnFqKFMaKUpS01GteX4lYQa-TJVEsciB2NgVKhCZjtcMxEx-N0r5Co43hB3VDpsErwInKlwBf2QksHucCSRDIY3zFjTTpisU8SkLSdYnRXwu0e44BLb5ZoX_N_2LXKzDlz9rtO022TJFHfIDffUz3fNTHfJcGvuNMovrd-r67zmU38wnsBn_9RodJW-Ovf73aN-sFkOAuoffsKiwMIfQNoO6_zj6zd3pdEwlOOLfzO9R04uRcr3yXJRFuYh8RMRZwri2iTjJo5sIlRkNacQmShuQdYeCRbClHlNbI7na3yUkOCg8GUtfOmE75G1Bn_mKD3-inyLa9OgkIq7GignI1nvbNlJBRex5blWOWTHSihBIQ5jkTFpkmTaI6u4stL1tTYGRXbTEM0pT-BvnlcIpOMosN5nlM2nU9k7HPwHqH_UAq3VIFuCCPKs7rEAQSLNVwv5qoUcOZLzPwFXWkCwPnl7eqGwsrZ-U_lrr3rkWTONV2JFX2FA8QCD3kNAgOqRB06_GzlDUgBhaso9krY0v7UQ7ZlifFpxowuklIzZo3_f1iq5tnO8vyf3ege7j8l1ii0tVRHrClmeTebmCQSaM_W02t0--XDZ5uQnN4CMvg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3dbtMwFLbGkBASQvxTGCwgYFehiR079QVCZaVaGWxo3arehTi2u0qQjqYV2h3vwNvwODwJ58RpWMSPuNlNK9lfmvb4-Pyk53wm5IlF8tvAMD_jRviRpamfKiZ8KzosDbGpq2TXf7cndo6iN2M-XiPfV70wWFa5somlodazDJ-Rt6kA3wfONojatiqLeN_rvzz57OMJUvhP6-o4Daciu-b0C6RvxYtBD9b6KaX914fbO351woCfxTxa-DbSFn4DEyKVilFDmdRKUxablGor8I0HGrkzFY8imYFhMCpQAbMdoZkMGXzuBXIxZjzEPRaP62QvBMcqXXE_pGewUxxhJIPhtplq2gn4c4qYuOEQy3MDfvcOZ9xjs3TzjC_sXyNXqyDW6zqtu07WTH6DXHFPAD3X2HSTjHtLp13ezHqDquZrWXij6Rxeh8dGo9v01Kk37B4M_e3ZyKfe_icsEMy9EaTwsOY_vn5zVxoNQxkWAZjiFjk6FynfJuv5LDd3icdllCqIcXkqTBRaLlVotaAQpShhQdYt4q-EmWQVyTmetfExgWQHhZ9Uwk-c8Ftkq8afOHqPvyJf4drUKKTlLgdm80lS7fKkE0shIysyrTLIlJVUkkJMxkJjYs5T3SKbuLKJ63GtjUvSjQM0rYLDbR6XCKTmyFHJJ-myKJLB_ug_QMODBmirAtkZiCBLq34LECRSfjWQzxrIiSM8_xNwowEES5Q1p1cKm1SWsEh-7dsWeVRP45VY3ZcbUDzAoCeREKy2yB2n37WcIUGAkDUWLRI3NL-xEM2ZfHpc8qRLpJeM2L1_f61NcgkMSfJ2sLd7n1ym2N1S1rNukPXFfGkeQMy5UA_Lze2RD-dtTX4CB8-Q9A
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Duration+of+Infectious+Virus+Shedding+by+SARS-CoV-2+Omicron+Variant-Infected+Vaccinees&rft.jtitle=Emerging+infectious+diseases&rft.au=Takahashi%2C+Kenichiro&rft.au=Ishikane%2C+Masahiro&rft.au=Ujiie%2C+Mugen&rft.au=Iwamoto%2C+Noriko&rft.date=2022-05-01&rft.pub=U.S.+National+Center+for+Infectious+Diseases&rft.issn=1080-6040&rft.volume=28&rft.issue=5&rft.spage=998&rft_id=info:doi/10.3201%2Feid2805.220197&rft.externalDBID=ISR&rft.externalDocID=A701832657
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1080-6040&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1080-6040&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1080-6040&client=summon